D.E. Shaw & Co’s Athenahealth, Inc. ATHN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q1 | – | Sell |
-17,300
| Closed | -$1.82M | – | 3732 |
|
|
2016
Q4 | $1.82M | Buy |
+17,300
| New | +$1.86M | ﹤0.01% | 2061 |
|
|
2016
Q1 | – | Sell |
-17,900
| Closed | -$2.88M | – | 3956 |
|
|
2015
Q4 | $2.88M | Sell |
17,900
-20,000
| -53% | -$3.09M | ﹤0.01% | 1851 |
|
|
2015
Q3 | $5.05M | Sell |
37,900
-5,100
| -12% | -$665K | 0.01% | 1386 |
|
|
2015
Q2 | $4.93M | Sell |
43,000
-4,800
| -10% | -$574K | 0.01% | 1479 |
|
|
2015
Q1 | $5.71M | Buy |
47,800
+18,700
| +64% | +$2.49M | 0.01% | 1292 |
|
|
2014
Q4 | $4.24M | Sell |
29,100
-4,600
| -14% | -$578K | 0.01% | 1693 |
|
|
2014
Q3 | $4.44M | Sell |
33,700
-17,500
| -34% | -$2.3M | 0.01% | 1649 |
|
|
2014
Q2 | $6.41M | Buy |
51,200
+17,800
| +53% | +$2.3M | 0.01% | 1424 |
|
|
2014
Q1 | $5.35M | Buy |
33,400
+2,500
| +8% | +$411K | 0.01% | 1532 |
|
|
2013
Q4 | $4.16M | Buy |
+30,900
| New | +$3.97M | 0.01% | 1852 |
|
D.E. Shaw & Co's ATHN Position: Q1 2019 in Review
D.E. Shaw & Co sold out of Athenahealth, Inc. (ATHN) in Q1 2019, closing a stake of 67,636 shares — an estimated $8.92M sold.
D.E. Shaw & Co first reported a position in ATHN in Q2 2013 and held it in 13 quarters. The position peaked at $21.8M in Q2 2017. 0 funds tracked by Wall St. Rank hold ATHN as of Q1 2019.
- D.E. Shaw & Co reported no remaining Athenahealth, Inc. position as of Q1 2019 after selling out during the quarter.
- D.E. Shaw & Co sold 67,636 Athenahealth, Inc. shares in Q1 2019, an estimated $8.92M.
- D.E. Shaw & Co first reported a position in Athenahealth, Inc. in Q2 2013 and held it in 13 quarters.
- D.E. Shaw & Co's Athenahealth, Inc. position peaked at $21.8M in Q2 2017.
- 0 funds tracked by Wall St. Rank held Athenahealth, Inc. as of Q1 2019.
Based on D.E. Shaw & Co's 13F filing for Q1 2019, filed 15 May 2019.